Clinical Trials Browser

Phase 2 × HER2-positive Breast Cancer × Capecitabine × Clear all

NCT07166367 2025-09-10

Phase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast Cancer

Phase 2 Terminated

HER2-positive Breast Cancer

NCT03684863 2018-09-26

Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy

Phase 2 Unknown

HER2-positive Breast Cancer